Catalyst Pharmaceuticals CPRX
CPRX
$31.49 +0.00 (+0.00%)
At close: Jul 21, 2026 · 4:00 PM EDT

Catalyst Pharmaceuticals (CPRX) Cash & Equivalents (2010 - 2026)

Updated

Catalyst Pharmaceuticals (CPRX) posted Cash & Equivalents of $755.86 million for Q1 2026, up 30.2% from $580.66 million a year earlier and up 6.6% from the prior quarter.

Analysis

Catalyst Pharmaceuticals (CPRX) Cash & Equivalents (2010 - 2026) Analysis & Trends

At the end of FY2025, Catalyst Pharmaceuticals' Cash & Equivalents came in at $709.17 million, up 37.0% from FY2024.

  • Annual Cash & Equivalents shows a five-year compound annual growth rate of 40.3% (FY2020 to FY2025).
  • In prior years, Catalyst Pharmaceuticals' Cash & Equivalents was $517.55 million in FY2024 (+276.0%), $137.64 million in FY2023 (-53.9%), $298.4 million in FY2022 (+74.0%) and $171.45 million in FY2021 (+31.6%).
  • The Q1 2026 figure stands as the highest quarterly Cash & Equivalents in data going back to Q3 2010.
  • On a year-over-year basis, Cash & Equivalents has increased in each of the last nine quarters, with growth averaging 117.0% over the last eight quarters.
  • The strongest year-over-year quarter for Cash & Equivalents in the past five years was Q4 2024, with growth of 276.0%; the weakest was Q4 2023, with a decline of 53.9%.
  • According to Business Quant data, Cash & Equivalents for the three prior quarters was $709.17 million (Q4 2025), $689.89 million (Q3 2025) and $652.8 million (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 20.42 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 6.57 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 6.85 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 7.62 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 4.89 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 13.99 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 3.18 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 976.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 6.14 Bn
10 Catalyst Pharmaceuticals 3.85 Bn 1.04 Bn 134.92 Mn 755.86 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 755.86 Mn
Dec 31, 2025 709.17 Mn
Sep 30, 2025 689.89 Mn
Jun 30, 2025 652.80 Mn
Mar 31, 2025 580.66 Mn
Dec 31, 2024 517.55 Mn
Sep 30, 2024 442.33 Mn
Jun 30, 2024 375.69 Mn
Mar 31, 2024 310.41 Mn
Dec 31, 2023 137.64 Mn
Sep 30, 2023 120.97 Mn
Jun 30, 2023 178.79 Mn
Mar 31, 2023 148.25 Mn
Dec 31, 2022 298.40 Mn
Sep 30, 2022 256.07 Mn
Jun 30, 2022 210.91 Mn
Mar 31, 2022 178.37 Mn
Dec 31, 2021 171.45 Mn
Sep 30, 2021 154.84 Mn
Jun 30, 2021 135.30 Mn
API Access

Catalyst Pharmaceuticals Cash & Equivalents API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=CPRX&period=max&api_key=YOUR_API_KEY